Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

The Blood Oxygenation T2* Values of Resectable Esophageal Squamous Cell Carcinomas as Measured by 3T Magnetic Resonance Imaging: Association with Tumor Stage

  • Tang, Yu-lian (Sichuan Key Laboratory of Medical Imaging, Affiliated Hospital of North Sichuan Medical College) ;
  • Zhang, Xiao-ming (Sichuan Key Laboratory of Medical Imaging, Affiliated Hospital of North Sichuan Medical College) ;
  • Yang, Zhi-gang (Department of Radiology, West China Hospital of Sichuan University) ;
  • Huang, Yu-cheng (Sichuan Key Laboratory of Medical Imaging, Affiliated Hospital of North Sichuan Medical College) ;
  • Chen, Tian-wu (Sichuan Key Laboratory of Medical Imaging, Affiliated Hospital of North Sichuan Medical College) ;
  • Chen, Yan-li (Sichuan Key Laboratory of Medical Imaging, Affiliated Hospital of North Sichuan Medical College) ;
  • Chen, Fan (Sichuan Key Laboratory of Medical Imaging, Affiliated Hospital of North Sichuan Medical College) ;
  • Zeng, Nan-lin (Sichuan Key Laboratory of Medical Imaging, Affiliated Hospital of North Sichuan Medical College) ;
  • Li, Rui (Sichuan Key Laboratory of Medical Imaging, Affiliated Hospital of North Sichuan Medical College) ;
  • Hu, Jiani (Department of Radiology, Wayne State University)
  • Received : 2016.05.29
  • Accepted : 2016.11.22
  • Published : 2017.08.01
⟨ Previous Next ⟩

Abstract

Objective: To explore the association between the blood oxygenation ${T_2}^*$ values of resectable esophageal squamous cell carcinomas (ESCCs) and tumor stages. Materials and Methods: This study included 48 ESCC patients and 20 healthy participants who had undergone esophageal ${T_2}^*$-weighted imaging to obtain ${T_2}^*$ values of the tumors and normal esophagi. ESCC patients underwent surgical resections less than one week after imaging. Statistical analyses were performed to identify the association between ${T_2}^*$ values of ESCCs and tumor stages. Results: One-way ANOVA and Student-Newman-Keuls tests revealed that the ${T_2}^*$ value could differentiate stage T1 ESCCs ($17.7{\pm}3.3ms$) from stage T2 and T3 tumors ($24.6{\pm}2.7ms$ and $27.8{\pm}5.6ms$, respectively; all $p_s$ < 0.001). Receiver operating curve (ROC) analysis showed the suitable cutoff ${T_2}^*$ value of 21.3 ms for either differentiation. The former statistical tests demonstrated that the ${T_2}^*$ value could not differentiate between stages T2 and T3 ($24.6{\pm}2.7ms$ vs. $27.8{\pm}5.6ms$, respectively, p > 0.05) or between N stages (N1 vs. N2 vs. N3: $24.7{\pm}6.9ms$ vs. $25.4{\pm}4.5ms$ vs. $26.8{\pm}3.9ms$, respectively; all $p_s$ > 0.05). The former tests illustrated that the ${T_2}^*$ value could differentiate anatomic stages I and II ($18.8{\pm}4.8ms$ and $26.9{\pm}5.9ms$, respectively) or stages I and III ($27.3{\pm}3.6ms$). ROC analysis depicted the same cutoff ${T_2}^*$ value of 21.3 ms for either differentiation. In addition, the Student's t test revealed that the ${T_2}^*$ value could determine grouped T stages (T0 vs. T1-3: $17.0{\pm}2.9ms$ vs. $25.2{\pm}6.2ms$; T0-1 vs. T2-3: $17.3{\pm}3.0ms$ vs. $27.1{\pm}5.3ms$; and T0-2 vs. T3: $18.8{\pm}4.2ms$ vs. $27.8{\pm}5.6ms$, all $p_s$ < 0.001). ROC analysis indicated that the ${T_2}^*$ value could detect ESCCs (cutoff, 20 ms), and discriminate between stages T0-1 and T2-3 (cutoff, 21.3 ms) and between T0-2 and T3 (cutoff, 20.4 ms). Conclusion: The ${T_2}^*$ value can be an additional quantitative indicator for detecting ESCC except for stage T1 cancer, and can preoperatively discriminate between some T stages and between anatomic stages of this tumor.

Keywords

Acknowledgement

Supported by : National Natural Science Foundation of China, Sichuan Provincial Colleges and Universities

References

  1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-2252 https://doi.org/10.1056/NEJMra035010
  2. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366:2074-2084 https://doi.org/10.1056/NEJMoa1112088
  3. Cao LY, Yin Y, Li H, Jiang Y, Zhang HF. Expression and clinical significance of S100A2 and p63 in esophageal carcinoma. World J Gastroenterol 2009;15:4183-4188 https://doi.org/10.3748/wjg.15.4183
  4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90 https://doi.org/10.3322/caac.20107
  5. Fitzgerald RC. Review article: Barrett's oesophagus and associated adenocarcinoma--a UK perspective. Aliment Pharmacol Ther 2004;20 Suppl 8:45-49
  6. Nomura M, Oze I, Kodaira T, Abe T, Komori A, Narita Y, et al. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis. Int J Clin Oncol 2016;21:890-898 https://doi.org/10.1007/s10147-016-0963-3
  7. Kitagawa Y. [Therapeutic strategies for advanced respectable esophageal cancer]. Nihon Geka Gakkai Zasshi 2008;109:333-337
  8. Fokas E, Rodel C. Definitive, preoperative, and palliative radiation therapy of esophageal cancer. Viszeralmedizin 2015;31:347-353
  9. Ripley RT, Sarkaria IS, Grosser R, Sima CS, Bains MS, Jones DR, et al. Pretreatment dysphagia in esophageal cancer patients may eliminate the need for staging by endoscopic ultrasonography. Ann Thorac Surg 2016;101:226-230 https://doi.org/10.1016/j.athoracsur.2015.06.062
  10. Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 2008;14:1479-1490 https://doi.org/10.3748/wjg.14.1479
  11. Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 2000;10:471-485
  12. Riddell AM, Allum WH, Thompson JN, Wotherspoon AC, Richardson C, Brown G. The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation. Eur Radiol 2007;17:391-399 https://doi.org/10.1007/s00330-006-0363-6
  13. Riddell AM, Hillier J, Brown G, King DM, Wotherspoon AC, Thompson JN, et al. Potential of surface-coil MRI for staging of esophageal cancer. AJR Am J Roentgenol 2006;187:1280-1287 https://doi.org/10.2214/AJR.05.0559
  14. Tang MY, Chen TW, Zhang XM, Huang XH. GRE T2*-weighted MRI: principles and clinical applications. Biomed Res Int 2014;2014:312142
  15. Li Y, Song QW, Sun MY, Wang HQ, Wang S, Wei Q, et al. Use of enhanced T2 star-weighted angiography (ESWAN) and R2* values to distinguish ovarian cysts due to endometriosis from other causes. Abdom Imaging 2015;40:1733-1741 https://doi.org/10.1007/s00261-014-0314-7
  16. Howe FA, Robinson SP, Rodrigues LM, Stubbs M, Griffiths JR. Issues in GRE & SE magnetic resonance imaging to probe tumor oxygenation. Adv Exp Med Biol 2003;530:441-448
  17. Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM. Principles, techniques, and applications of T2*-based MR imaging and its special applications. Radiographics 2009;29:1433-1449 https://doi.org/10.1148/rg.295095034
  18. Rodrigues LM, Howe FA, Griffiths JR, Robinson SP. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors. J Magn Reson Imaging 2004;19:482-488 https://doi.org/10.1002/jmri.20024
  19. Zhang LJ, Zhang Z, Xu J, Jin N, Luo S, Larson AC, et al. Carbogen gas-challenge blood oxygen level-dependent magnetic resonance imaging in hepatocellular carcinoma: initial results. Oncol Lett 2015;10:2009-2014 https://doi.org/10.3892/ol.2015.3526
  20. Li D, Wang X, Wang S, Cheng J. Correlation between BOLDMRI and HIF expression level in renal carcinoma. Int J Clin Exp Pathol 2015;8:13759-13763
  21. Rakow-Penner R, Daniel B, Glover GH. Detecting blood oxygen level-dependent (BOLD) contrast in the breast. J Magn Reson Imaging 2010;32:120-129 https://doi.org/10.1002/jmri.22227
  22. Alonzi R, Padhani AR, Maxwell RJ, Taylor NJ, Stirling JJ, Wilson JI, et al. Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans. Br J Cancer 2009;100:644-648 https://doi.org/10.1038/sj.bjc.6604903
  23. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet 2013;381:400-412 https://doi.org/10.1016/S0140-6736(12)60643-6
  24. Li Z, Rice TW. Diagnosis and staging of cancer of the esophagus and esophagogastric junction. Surg Clin North Am 2012;92:1105-1126 https://doi.org/10.1016/j.suc.2012.07.010
  25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310
  26. Quint LE, Bogot NR. Staging esophageal cancer. Cancer Imaging 2008;8:S33-S42 https://doi.org/10.1102/1470-7330.2008.9007
  27. Butler JM, Kobayashi H, Rafii S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 2010;10:138-146 https://doi.org/10.1038/nrc2791
  28. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-674 https://doi.org/10.1016/j.cell.2011.02.013
  29. Gholamin M, Moaven O, Memar B, Farshchian M, Naseh H, Malekzadeh R, et al. Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma. World J Surg 2009;33:1439-1445 https://doi.org/10.1007/s00268-009-0070-y
  30. Wang W, Sun QK, He YF, Ma DC, Xie MR, Ji CS, et al. Overexpression of periostin is significantly correlated to the tumor angiogenesis and poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014;7:593-601
  31. Koga T, Shibahara K, Kabashima A, Sumiyoshi Y, Kimura Y, Takahashi I, et al. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer. Hepatogastroenterology 2004;51:1626-1630
  32. Kumagai Y, Sobajima J, Higashi M, Ishiguro T, Fukuchi M, Ishibashi K, et al. Coexpression of COX-2 and iNOS in angiogenesis of superficial esophageal squamous cell carcinoma. Int Surg 2015;100:733-743 https://doi.org/10.9738/INTSURG-D-14-00234.1
  33. Pedersen M, Dissing TH, Morkenborg J, Stodkilde-Jorgensen H, Hansen LH, Pedersen LB, et al. Validation of quantitative BOLD MRI measurements in kidney: application to unilateral ureteral obstruction. Kidney Int 2005;67:2305-2312 https://doi.org/10.1111/j.1523-1755.2005.00334.x
  34. Van Meir E. Hypoxia-mediated selection of cells with diminished apoptotic potential to solid tumours. Neurosurgery 1996;39:878-879 https://doi.org/10.1097/00006123-199610000-00057
  35. He Q, Xu RZ, Shkarin P, Pizzorno G, Lee-French CH, Rothman DL, et al. Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment. Dis Markers 2003-2004;19:69-94 https://doi.org/10.1155/2004/424395
  36. Arakelyan L, Vainstein V, Agur Z. A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth. Angiogenesis 2002;5:203-214 https://doi.org/10.1023/A:1023841921971
  37. Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992;52:5110-5114
  38. Horsman MR, Overgaard J. The impact of hypoxia and its modification of the outcome of radiotherapy. J Radiat Res 2016;57 Suppl 1:i90-i98 https://doi.org/10.1093/jrr/rrw007

Cited by

  1. A case report and literature review of barium sulphate aspiration during upper gastrointestinal examination vol.96, pp.47, 2017, https://doi.org/10.1097/md.0000000000008821
  2. Age of Data in Contemporary Research Articles Published in Representative General Radiology Journals vol.19, pp.6, 2018, https://doi.org/10.3348/kjr.2018.19.6.1172
  3. An Esophagogram or Tracheobronchogram? A Review of Barium Sulfate Aspiration vol.6, pp.None, 2017, https://doi.org/10.1177/2324709618802872
  4. The value of magnetic resonance imaging in esophageal carcinoma: Tool or toy? vol.15, pp.3, 2017, https://doi.org/10.1111/ajco.13112
  5. Quantitative T2*-Weighted Imaging and Reduced Field-of-View Diffusion-Weighted Imaging of Rectal Cancer: Correlation of R2* and Apparent Diffusion Coefficient With Histopathological Prognostic Factors vol.11, pp.None, 2021, https://doi.org/10.3389/fonc.2021.670156
  6. Diagnostic Performance of MRI for Esophageal Carcinoma: A Systematic Review and Meta-Analysis vol.299, pp.3, 2021, https://doi.org/10.1148/radiol.2021202857